NIH Statement: Protecting the Integrity of U.S. Biomedical Research

August 27, 2018

Francis S. Collins, M.D., Ph.D., Director, National Institutes of Health, released a statement reinforcing the agency's committment to the principles of scientific excellence, unassailable integrity, and fair competition. He notes that "the robustness of the biomedical research enterprise is under constant threat by risks to the security of intellectual property and the integrity of peer review. This knowledge has shaped our existing policies and practices, but these risks are increasing."  Read more...